Ørsted (ORSTED) Q4 2023 (Media) earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 (Media) earnings summary
4 Nov, 2026Executive summary
FY 2023 EBITDA excluding new partnerships and cancellation fees was DKK 24.0bn, slightly above the DKK 20–23bn guidance range.
Portfolio review shifted investment toward value-accretive opportunities in priority markets, with a strengthened project execution model and measures to support balance-sheet resilience.
The revised plan targets 35–38 GW of installed renewable capacity and DKK 39–43bn EBITDA in 2030, supported by DKK 270bn of gross investments over 2024–2030.
Financial highlights
FY 2023 EBITDA was DKK 24.0bn excluding new partnerships and cancellation fees, versus DKK 21.1bn on the same basis in 2022; reported EBITDA was DKK 18.7bn.
FY 2023 impairments totaled DKK 26.8bn, including DKK 19.9bn for Ocean Wind 1; cancellation-fee provision was DKK 9.6bn.
FY 2023 revenue was DKK 79.3bn, down 31% YoY; taxonomy-aligned revenue was 86%, up 17 percentage points.
FY 2023 adjusted ROCE was 12.9%, excluding impairment losses and cancellation fees.
Outlook and guidance
2024 EBITDA guidance is DKK 23–26bn, excluding new partnerships and cancellation fees; higher Offshore Sites earnings are expected to be partly offset by weaker partnership earnings and higher DEVEX.
EBITDA targets are DKK 30–34bn in 2026 and DKK 39–43bn in 2030, excluding new partnerships and cancellation fees; the 2030 target implies 8% CAGR, versus the prior DKK 50–55bn target and 13–14% CAGR.
Installed renewable capacity ambition is ~23 GW by 2026 and 35–38 GW by 2030, from 15.7 GW in 2023; the prior 2030 ambition was ~50 GW.
Average ROCE target is ~14% for 2024–2030; targeted fully loaded project lifecycle IRR spread to WACC is 150–300 bps at bid or FID, whichever comes first.
Latest events from Ørsted
- Adjusted EBITDA grew, but US impairments drove a Q3 loss as offshore projects advanced.ORSTED
Q3 2026 - 2023 EBITDA guidance of DKK 20bn–23bn rests on renewable recovery amid hedge and project risks.ORSTED
Guidance - Portfolio reset targets 35–38 GW of renewables by 2030 with tighter risk controls.ORSTED
Q4 2023 & Capital Markets Update - FY 2026 EBITDA guidance tops DKK 28bn as higher US rates raise impairment sensitivity.ORSTED
Pre-Close Call Presentation - H1 2026 EBITDA up, revenue rises 28%, profit drops on impairments; 2026 outlook reaffirmed.ORSTED
Q2 2026 - EBITDA set to exceed DKK 28 bn in 2026, with major divestments and improved ROCE outlook.ORSTED
Pre-Close Call Presentation - EBITDA to surpass DKK 28 bn in 2026, with major investments and US-driven impairments.ORSTED
Pre-Close Call Presentation - Key AGM resolutions passed; offshore wind strategy continued amid U.S. delays.ORSTED
AGM 2026 - Value-focused refocus, U.S. impairments and no FY2024 dividend; key AGM items approved.ORSTED
AGM 2025